Cargando…
Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy
Given the growing interest in using proton beam therapy (PBT) for hepatocellular carcinoma (HCC), it is possible that transarterial chemoembolization (TACE) could be used for selected patients who have previously undergone PBT. However, these cases can be technically challenging to treat and require...
Autores principales: | Takahashi, Hiroaki, Mori, Kensaku, Sekino, Yuta, Okumura, Toshiyuki, Hiyama, Takashi, Fukuda, Kuniaki, Hasegawa, Naoyuki, Sakai, Masafumi, Kikuchi, Shunsuke, Takei, Yohei, Iizumi, Takashi, Sakurai, Hideyuki, Minami, Manabu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637669/ https://www.ncbi.nlm.nih.gov/pubmed/31354819 http://dx.doi.org/10.1155/2019/3580379 |
Ejemplares similares
-
Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020) -
Proton beam therapy for hepatocellular carcinoma with bile duct invasion
por: Iizumi, Takashi, et al.
Publicado: (2023) -
Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
por: Iizumi, Takashi, et al.
Publicado: (2021) -
Proton beam therapy for renal pelvis and ureter cancer: A report of 5 cases and a literature review
por: Iizumi, Takashi, et al.
Publicado: (2019) -
Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
por: Fukuda, Kuniaki, et al.
Publicado: (2017)